Documentjamaneurology_mendell_2021_oi_210023_1624467431.00495încărcat de
alvaro.bosch.ibanez- Documentinformeîncărcat dealvaro.bosch.ibanez
- Documentinforme (1)încărcat dealvaro.bosch.ibanez
- Documentinforme (2)încărcat dealvaro.bosch.ibanez
- DocumentAtrofia_muscular_espinalîncărcat dealvaro.bosch.ibanez
- DocumentGil Lizarraga, Uxueîncărcat dealvaro.bosch.ibanez
- DocumentSpinal Muscular Atrophyîncărcat dealvaro.bosch.ibanez
- DocumentSafety and efficacy of nusinersen in spinal muscular atrophy The EMBRACE studyîncărcat dealvaro.bosch.ibanez
- DocumentSpinal muscular atrophy From approved therapies to future therapeutic targets for personalized medicineîncărcat dealvaro.bosch.ibanez
- DocumentNew and Developing Therapies in Spinal Muscularîncărcat dealvaro.bosch.ibanez
- DocumentExpert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophyîncărcat dealvaro.bosch.ibanez
- DocumentFive-Year Extension Results of the Phase 1 START Trialîncărcat dealvaro.bosch.ibanez
- DocumentAdvances and limitations for the treatment of spinal muscular atrophyîncărcat dealvaro.bosch.ibanez
Documente Academic
Documente Profesional
Documente Cultură
